Weight loss peptides (GLP-1 agonists) Examples : Semaglutide, Tirzepatide, Liraglutide Common side effects (mostly GI-related): Nausea : Frequency: 40-50% of users initially Severity: Mild to moderate Duration: Usually 1-3 weeks (improves with continued use) Management: Start low dose, increase gradually, eat smaller meals Constipation : Frequency: 20-30% of users Severity: Mild to moderate Management: Increase fiber, water, consider stool softener Diarrhea : Frequency: 15-20% of users Severity: Mild Duration: Usually temporary Management: Probiotics, reduce fatty foods Fatigue : Frequency: 20-30% initially Severity: Mild to moderate Duration: 2-4 weeks (improves as caloric deficit stabilizes) Management: Adequate protein, electrolytes, patience Reduced appetite (intended effect): Not a side effect - this is the mechanism Goal: 15-20% reduction in caloric intake Result: Weight loss Read our semaglutide vs tirzepatide comparison
Tirzepatide has a roughly 5-day half-life, so there will still be residual drug in your system when you begin sublingual dosing
Special features Free of fragrance, silicones, sulfates, harsh alcohols & parabens
Its primary mechanism is increasing VEGF expression (vascular endothelial growth factor), which promotes new blood vessel growth at injury sites
"Executive management should immediately and comprehensively assess your companys global manufacturing operations to ensure that your systems, processes, and products conform to FDA requirements," the agency added
[DOI] [PubMed] [Google Scholar] 5.Mascagni P., Consonni D., Bregante G., Chiappino G., Toffoletto F
